What Theranos taught investors about commercialization in health care, MarketWatch by Matthew McCooe, Connecticut Innovations
Matthew McCooe’s piece deconstructs the effects of the Theranos fallout, translating what is easily viewed as an obstacle into a horizon of opportunity for investors. The lesson here points to the need to find better ways to protect investment bets, and in bioscience, research reproducibility is key. By exemplifying the critical importance of research verification, Matthew offers specific bioscience investment strategies vital to the due diligence process.
[/cs_text][/cs_column][/cs_row][/cs_section][cs_section parallax=”false” separator_top_type=”none” separator_top_height=”50px” separator_top_angle_point=”50″ separator_bottom_type=”none” separator_bottom_height=”50px” separator_bottom_angle_point=”50″ class=”cs-ta-left” style=”margin: 0px;padding: 45px 0px;”][cs_row inner_container=”true” marginless_columns=”false” style=”margin: 0px auto;padding: 0px;”][cs_column fade=”false” fade_animation=”in” fade_animation_offset=”45px” fade_duration=”750″ type=”1/1″ style=”padding: 0px;”][x_image type=”none” src=”http://ctinnovations.com/wp-content/uploads/2017/04/backtocontentlibrary.png” alt=”back to content library” link=”true” href=”http://ctinnovations.com/access-content-library/” title=”” target=”” info=”none” info_place=”top” info_trigger=”hover” info_content=”” class=”back-image”][/cs_column][/cs_row][/cs_section][/cs_content]